Search

Search Constraints

You searched for: Author/Creator Cappuzzo, F.

Search Results

1. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. (August 2020)

2. Global named patient use (NPU) program of afatinib in heavily pretreated advanced NSCLC patients who progressed following prior therapies, including erlotinib or gefitinib. (February 2017)

4. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. (August 2020)